Insulin aspart, recombinant Subcutaneous and Oxycodone and naloxone
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Oxycodone and naloxone and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: naloxone / oxycodone
Brand name: Targiniq ER
Synonyms: Oxycodone and naloxone (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Oxycodone and naltrexone
- Insulin aspart, recombinant Subcutaneous-Oxycodone Capsules
- Insulin aspart, recombinant Subcutaneous-Oxycodone Capsules and Tablets
- Insulin aspart, recombinant Subcutaneous-Oxycodone Concentrate
- Insulin aspart, recombinant Subcutaneous-Oxycodone ER
- Insulin aspart, recombinant Subcutaneous-Oxycodone Extended-Release Capsules
- Oxycodone and naloxone-Insulin degludec
- Oxycodone and naloxone-Insulin Degludec (U-100) Prefilled Pens
- Oxycodone and naloxone-Insulin Degludec (U-100) Vials
- Oxycodone and naloxone-Insulin Degludec (U-200) Prefilled Pens
- Oxycodone and naloxone-Insulin degludec and liraglutide
- Oxycodone and naloxone-Insulin degludec and liraglutide Subcutaneous